Effect of everolimus on skin cancers in calcineurin inhihitor-treated heart transplant recipients

Transpl Int. 2010 Aug;23(8):855-7. doi: 10.1111/j.1432-2277.2009.01010.x. Epub 2009 Nov 27.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Calcineurin Inhibitors
  • Carcinoma, Basal Cell / immunology
  • Carcinoma, Basal Cell / prevention & control
  • Carcinoma, Squamous Cell / immunology
  • Carcinoma, Squamous Cell / prevention & control*
  • Everolimus
  • Graft Rejection / drug therapy*
  • Graft Rejection / immunology
  • Heart Transplantation / immunology*
  • Humans
  • Immunosuppressive Agents / administration & dosage
  • Male
  • Middle Aged
  • Sirolimus / administration & dosage
  • Sirolimus / analogs & derivatives*
  • Skin Neoplasms / immunology
  • Skin Neoplasms / prevention & control*

Substances

  • Calcineurin Inhibitors
  • Immunosuppressive Agents
  • Everolimus
  • Sirolimus